Detalhes do Documento

Highlights on Steroidal Arylidene Derivatives as a Source of Pharmacologically Active Compounds: A Review

Autor(es): Brito, Vanessa ; Alves, Gilberto ; Almeida, Paulo ; Silvestre, Samuel

Data: 2021

Identificador Persistente: https://hdl.handle.net/10316/105261

Origem: Estudo Geral - Universidade de Coimbra

Projeto/bolsa: info:eu-repo/grantAgreement/FCT/UID/Multi/PT;

Assunto(s): steroids; arylidenesteroids; aldol condensation; bioactivity; heterocycles; Benzylidene Compounds; Models, Molecular; Steroids


Descrição

Steroids constitute a unique class of chemical compounds, playing an important role in physiopathological processes, and have high pharmacological interest. Additionally, steroids have been associated with a relatively low toxicity and high bioavailability. Nowadays, multiple steroidal derivatives are clinically available for the treatment of numerous diseases. Moreover, different structural modifications on their skeleton have been explored, aiming to develop compounds with new and improved pharmacological properties. Thus, steroidal arylidene derivatives emerged as a relevant example of these modifications. This family of compounds has been mainly described as 17β-hydroxysteroid dehydrogenase type 1 and aromatase inhibitors, as well as neuroprotective and anticancer agents. Besides, due to their straightforward preparation and intrinsic chemical reactivity, steroidal arylidene derivatives are important synthetic intermediates for the preparation of other compounds, particularly bearing heterocyclic systems. In fact, starting from arylidenesteroids, it was possible to develop bioactive steroidal pyrazolines, pyrazoles, pyrimidines, pyridines, spiro-pyrrolidines, amongst others. Most of these products have also been studied as anti-inflammatory and anticancer agents, as well as 5α-reductase and aromatase inhibitors. This work aims to provide a comprehensive overview of steroidal arylidene derivatives described in the literature, highlighting their bioactivities and importance as synthetic intermediates for other pharmacologically active compounds.

FEDER funds through the POCI-COMPETE 2020-Operational Programme Competitiveness and Internationalization in Axis I-Strengthening Research, Technological Development and Innovation (Project No. 007491) grant SFRH/BD/131059/2017. C4-Cloud Computing Competences Center project (CENTRO-01-0145-FEDER-000019)

Tipo de Documento Artigo científico
Idioma Inglês
facebook logo  linkedin logo  twitter logo 
mendeley logo

Documentos Relacionados